Livzon Pharmaceutical Group

Company snapshot

Livzon is Always Committed to Human Healthcare Livzon Pharmaceutical Group Inc., established in January 1985 with registered capital of 953 million yuan, is a comprehensive pharmaceutical group company integrating pharmaceutical R&D, production and sales, with more than 9,000 employees. In 1993, Livzon A and B shares have been listed. In 2014, the company completed the conversion from B shares to

• 2 active pipeline program(s) linked via ClinicalTrials.gov.
• 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Livzon Pharmaceutical Group. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Livzon Pharmaceutical Group.

1. Jun 8, 2026 Clinical update

   Recombinant SARS-CoV-2 fusion protein vaccine (V-01) — Phase 3

2. Jun 8, 2026 Clinical update

   Recombinant SARS-CoV-2 Fusion Protein Vaccine — Phase 1

View all clinical trial activity →

• What is Livzon Pharmaceutical Group?

  Livzon Pharmaceutical Group is a pharma organization headquartered in CN. Primary therapeutic focus areas include COVID19, COVID-19 Pandemic. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.

• Is Livzon Pharmaceutical Group publicly traded?

  Livzon Pharmaceutical Group appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Livzon Pharmaceutical Group develop or market?

  We link 3 drug profile(s) where Livzon Pharmaceutical Group is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/livzon-pharmaceutical-group#company-drugs.

• What are the latest developments for Livzon Pharmaceutical Group?

  In the last 12 months our linked public records show 2 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Livzon Pharmaceutical Group focus on?

  Livzon Pharmaceutical Group focuses on COVID19, COVID-19 Pandemic based on our analysis of their pipeline programs and drug development activities.